As of Sep 13
| +0.18 / +3.39%|
The 5 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +155.01% increase from the last price of 5.49.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.